{"id":12297,"date":"2026-05-14T15:40:11","date_gmt":"2026-05-14T06:40:11","guid":{"rendered":"https:\/\/microncro.com\/?post_type=solutions&p=12297"},"modified":"2026-06-10T20:55:10","modified_gmt":"2026-06-10T11:55:10","slug":"clinical_development_support","status":"publish","type":"solutions","link":"https:\/\/microncro.com\/en\/solutions\/clinical_development_support\/","title":{"rendered":"Clinical Development\u200b Support"},"content":{"rendered":"\n

Full support from early development through regulatory submission<\/h2>\n\n\n\n

We can flexibly provide services from partial trial outsourcing to comprehensive support for the entire development process.<\/p>\n\n\n\n

\"Clinical<\/figure>\n\n\n\n

We provide comprehensive, one-stop services for all clinical development needs, with experienced project managers collaborating closely with each specialized department. The Imaging CRA\u00ae system assigns highly knowledgeable CRAs, enabling smooth collaboration with the imaging department and rapid responses to queries.<\/p>\n\n\n

\n
\"Project<\/figure>\n<\/div>\n\n\n

Imaging-Based Monitoring for Clinical Trials \u201cImaging CRA\u00ae\u201d<\/h2>\n\n\n\n

Imaging CRA\u00ae<\/h3>\n\n\n\n

As an imaging CRO, we foster the development of \u201cImaging CRAs\u00ae,\u201d professionals who possess deep expertise in imaging technologies such as PET and advanced monitoring methodologies.<\/p>\n\n\n\n

\u201cAn Imaging CRA\u00ae not only possesses a thorough understanding of medical and pharmaceutical sciences as well as various regulatory guidelines ,but also has specialized expertise in imaging, enabling smooth site start-up. <\/p>\n\n\n\n

Furthermore, by leveraging our experience and adopting risk\u2011based monitoring (RBM) for imaging studies, we proactively identify imaging\u2011specific risks and ensure clinical trial quality efficiently and effectively.<\/p>\n\n\n

\n
\"Clinical<\/figure>\n<\/div>\n\n\n

Clinical studies involving PET have unique characteristics and differ in several important ways from studies that do not involve PET imaging.<\/p>\n\n\n\n

\n
\"\"
PET ligands have strict expiration timelines<\/strong><\/figcaption><\/figure>\n\n\n\n
\"\"
Collaboration with several internal hospital departments is necessary<\/strong><\/figcaption><\/figure>\n\n\n\n
\"\"
Verification of PET system quality control procedures<\/strong><\/figcaption><\/figure>\n\n\n\n
\"\"
Conducting a cold run prior to using the RI equipment<\/strong><\/figcaption><\/figure>\n<\/figure>\n\n\n\n

Clinical trials utilizing PET require additional monitoring activities beyond those of conventional studies. Micron\u2019s CRAs possess specialized training in imaging for clinical trials, enabling them to provide high\u2011quality monitoring services.<\/p>\n\n\n\n

\n
View Theranostics<\/a><\/div>\n<\/div>\n\n\n\n

FAQ<\/h2>\n\n\n\n
Is Micron\u2019s service limited to clinical trials requiring imaging?<\/strong>

Micron is primarily an imaging-focused CRO, but our services are not limited to clinical trials that use medical imaging. Regardless of whether imaging is involved, we provide flexible support tailored to the specific characteristics of each study.<\/p> <\/div>

What were the reasons for registering \u2018Imaging CRA\u00ae\u2019 as a trademark?<\/strong>

We were founded as Japan\u2019s first imaging CRO and\u00a0have led the domestic market in clinical development using\u00a0molecular imaging techniques that are widely used in\u00a0Europe and the United States. Through these efforts, we\u00a0obtained the trademark registration for \u2018Imaging CRA\u00ae.\u2019 in\u00a02005.<\/p> <\/div>

Can you also handle monitoring activities other than imaging\u2011based tests?<\/strong>

We specialize in study monitoring using imaging\u00a0technologies, but we also have experience in handling\u00a0several other types of studies and are fully capable of\u00a0Supporting them.<\/p> <\/div>

What are the strengths of statistical analysis as an imaging CRO?<\/strong>

Imaging diagnostics are used as objective evaluation metrics in the form of imaging biomarkers, contributing to highly objective clinical data analysis for drug efficacy assessment and clinical trial planning. We also have extensive experience in statistical analysis for Software as a Medical Device (SaMD), including AI\u2011powered diagnostic imaging applications. We provide consistent statistical support throughout all stages of the clinical development process, from early-phase planning to late-stage analysis.<\/p> <\/div>

We do not have in-house statistical experts. Would it still be possible to conduct a clinical study?<\/strong>

We provide support for study design and analysis from a statistical perspective. We can be involved from the planning stage, including assistance with study design and sample size calculations.<\/p> <\/div>

What data formats are supported by Micron’s DM?<\/strong>

Micron\u2019s DM supports not only EDC development but also a wide range of data formats, including CSV, SAS data, DICOM, and JSON. We can also handle video and image data and can propose solutions using our in\u2011house system, IRUM\u00aeneo. In addition, we have a proven track record in emerging fields such as SaMD and DTx<\/p> <\/div>

What are the features of Micron’s Clinical Research Medical Writing services\uff1f<\/strong>

We carefully assess and understand each client\u2019s needs and incorporate them into the overall study\u00a0design while considering relevant regulatory requirements. Based on this, we provide medical writing support with a clear focus on future regulatory submissions. Another strength is our ability to collaborate with related functions, such as statistical analysis, data management, and regulatory affairs, to prepare documentation that ensures consistency throughout the entire study.<\/p> <\/div>

Is it possible to request support even when only the basic framework of the project has been defined?<\/strong>

We are fully able to assist you. We provide support from the pre\u2011protocol development phase, helping you consider the overall study design and regulatory requirements to prepare high\u2011quality documentation. We are also available to assist with specific writing tasks, including drafting or reviewing individual documents. Please feel free to contact us at any time.\u3000<\/p> <\/div>

What kinds of documents can I ask you to create?<\/strong>

We provide support for the preparation and review of a wide range of clinical development documents, including study protocols, protocol synopses, informed consent forms, various standard operating procedures, clinical study reports, and regulatory submission materials.<\/p> <\/div>

Is it possible to support investigator-initiated clinical trials (IITs) and clinical research?<\/strong>

We are fully able to assist you.\u00a0We support\u00a0industry\u2011sponsored clinical trials, investigator\u2011initiated trials, and clinical research, from early development through regulatory submission. We can also serve\u00a0as a Clinical Trial Coordination Office or Research Administrative Office.<\/p> <\/div> <\/div>\n\n\n\t

\n\t\t\t\t\t

Solutions<\/h2>\n\t\t\t\t